Raj HC: Convicted Minor Gang Rapist Not Fully Barred From Open-Air Camps; Rules Allow Exceptions  ||  Calcutta High Court: Serving a Show-Cause Notice Via Email is Valid under PMLA Regulations  ||  Del HC: Candidate’s Independent Medical Opinions Don’t Justify Fresh Medical Exam in SSC Recruitment  ||  Calcutta HC: Magistrate Must Assess Grounds, Cannot Order Police Inquiry under Section 175(3) BNSS  ||  SC Grants Law Officer Exam Relief, Saying Students Can’t be Blamed When Judges Differ in Views  ||  SC: Fraudulent Diversion of Company Funds Cannot be Validated by Later Shareholder Ratification  ||  SC: Doctor’s View on a Victim’s Consciousness Prevails over Police Assessment in Dying Declarations  ||  SC: Examining Contradictions and Witness Credibility Exceeds the Scope of Section 319 CrPC  ||  Supreme Court Struck Down Section 60(4), Removing Limits on Maternity Benefits For Adoptive Mothers  ||  Supreme Court: Air Force Group Insurance Society qualifies as ‘State’ under Article 12    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved